Overview

Update
Acquisitions
1 Acquisition
Total Equity Funding
$49.08M in 3 Rounds from 8 Investors
Headquarters:
Boston, Massachusetts
Description:
Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.
Categories:
Therapeutics, Biotechnology, Life Science
Website:
http://www.epirusbiopharma.com
Social:

Company Details

Update

Funding Rounds (3) - $49.08M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2014$36M / Series B9
Jul, 2012$5M / Venture2
Apr, 2012$8.08M / Venture2

Acquisitions (1)

Update
DateAcquiredAmount
Sep 9, 2015$14.1M (terms undisclosed)

Current Team (10)

Update

Offices/Locations (1)

Update
  • HQ

    699 Boylston Street

    11th Floor

    Boston, Massachusetts 02116

    United States

Images (2)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos